'Aml patients' presentation slideshows

Epidemiology Subcommittee

816 views • 75 slides

Haploidentical Stem cell Transplantation

Haploidentical Stem cell Transplantation. Tsila Zuckerman Rambam Health Campus ISH 5/2009. Topics for discussion. Principles of haplo transplants Update data on haplo SCT( OS,DFS,TRM) Future directions (Improving results) in haplo (CTLs, T replete , NIMA) Pro & cons.

1.21k views • 47 slides

ASH review 2012 Acute leukemias

ASH review 2012 Acute leukemias. Tibor Kovacsovics Center for Hematologic Malignancies OHSU. Whole genome sequencing in acute leukemia. AML: - IDH and DMT3A are prototypes of genes identified by this approach - goal is to sequence a total of 500 AMLs

636 views • 46 slides

The Haematology Patient on the Intensive Care Unit

The Haematology Patient on the Intensive Care Unit. Association of North Western Intensive Care Units Annual Spring Meeting Manchester 30 th March 2012. Dr Paul Cahalin, Consultant Haematologist Blackpool Victoria Hospital. Overview to talk. Historical perspective Improvements

531 views • 31 slides

Shen Y et al. Blood 2011;118:5593-5603

Current Status of Acute Myeloid Leukemia in China Jianxiang Wang Institute of Hematology Hospital of Blood Disease Chinese Academy of Medical Sciences. AML Prognosis Factors (Shang Hai/Zhe Jiang Institute of Hematology ?. Shen Y et al. Blood 2011;118:5593-5603.

416 views • 30 slides

Alison Skinner Wessex Regional Genetics Laboratory

Development of a Diagnostic Test for Mutations in NPM1 Exon 12 in Cytogenetically Normal Acute Myeloid Leukaemia (AML) Patients. Alison Skinner Wessex Regional Genetics Laboratory. NPM1 function. Implicated in leukaemia as a translocation partner for various oncogenes

303 views • 15 slides

low

10 5. 10 5. 10 4. 10 4. 10 3. 10 3. 10 2. 10 2. 10 2. 10 2. 10 3. 10 3. 10 4. 10 4. 10 5. 10 5. A. (X1000). (X1000). 250. 250. 200. 200. SSC. SSC. CD34-PE-Cy7. CD34-PE-Cy7. 150. 150. 0.3%. 100. 100. 50. 50. 50. 100. 150. 200. 250. 10 2. 10 3. 10 4. 10 5.

210 views • 8 slides

low

10 5. 10 5. 10 4. 10 4. 10 3. 10 3. 10 2. 10 2. 10 2. 10 2. 10 3. 10 3. 10 4. 10 4. 10 5. 10 5. A. (X1000). (X1000). 250. 250. 200. 200. SSC. SSC. CD34-PE-Cy7. CD34-PE-Cy7. 150. 150. 0.3%. 100. 100. 50. 50. 50. 100. 150. 200. 250. 10 2. 10 3. 10 4. 10 5.

81 views • 8 slides